AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 179 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.80 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $9,000 | +28.6% | 397 | +13.4% | 0.00% | – |
| Q3 2019 | $7,000 | +250.0% | 350 | +302.3% | 0.00% | – |
| Q2 2019 | $2,000 | -66.7% | 87 | -30.4% | 0.00% | – |
| Q1 2019 | $6,000 | +500.0% | 125 | +557.9% | 0.00% | – |
| Q4 2018 | $1,000 | -99.5% | 19 | -99.5% | 0.00% | -100.0% |
| Q3 2017 | $204,000 | +2166.7% | 4,200 | +738.3% | 0.00% | – |
| Q3 2015 | $9,000 | 0.0% | 501 | -2.1% | 0.00% | – |
| Q2 2015 | $9,000 | +80.0% | 512 | +216.0% | 0.00% | – |
| Q1 2015 | $5,000 | +25.0% | 162 | 0.0% | 0.00% | – |
| Q4 2014 | $4,000 | – | 162 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |